[go: up one dir, main page]

FR2889662B1 - Emulsion de type huile-dans-eau pour application topique en dermatologie - Google Patents

Emulsion de type huile-dans-eau pour application topique en dermatologie

Info

Publication number
FR2889662B1
FR2889662B1 FR0508524A FR0508524A FR2889662B1 FR 2889662 B1 FR2889662 B1 FR 2889662B1 FR 0508524 A FR0508524 A FR 0508524A FR 0508524 A FR0508524 A FR 0508524A FR 2889662 B1 FR2889662 B1 FR 2889662B1
Authority
FR
France
Prior art keywords
dermatology
oil
water emulsion
topical application
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0508524A
Other languages
English (en)
Other versions
FR2889662A1 (fr
Inventor
Orsoni Sandrine Segura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0508524A priority Critical patent/FR2889662B1/fr
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to BRPI0616520-6A priority patent/BRPI0616520A2/pt
Priority to KR1020087003334A priority patent/KR20080033389A/ko
Priority to JP2008525600A priority patent/JP2009504619A/ja
Priority to CA002617963A priority patent/CA2617963A1/fr
Priority to EP06794313A priority patent/EP1915133A1/fr
Priority to RU2008108973/15A priority patent/RU2008108973A/ru
Priority to PCT/FR2006/001930 priority patent/WO2007020349A1/fr
Priority to MX2008002012A priority patent/MX2008002012A/es
Priority to CNA2006800374997A priority patent/CN101304729A/zh
Priority to AU2006281346A priority patent/AU2006281346B2/en
Publication of FR2889662A1 publication Critical patent/FR2889662A1/fr
Priority to US12/068,670 priority patent/US20080207570A1/en
Application granted granted Critical
Publication of FR2889662B1 publication Critical patent/FR2889662B1/fr
Priority to RU2011125550/15A priority patent/RU2011125550A/ru
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0508524A 2005-08-11 2005-08-11 Emulsion de type huile-dans-eau pour application topique en dermatologie Expired - Fee Related FR2889662B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0508524A FR2889662B1 (fr) 2005-08-11 2005-08-11 Emulsion de type huile-dans-eau pour application topique en dermatologie
AU2006281346A AU2006281346B2 (en) 2005-08-11 2006-08-09 Oil-in-water-type emulsion for topical application in dermatology
JP2008525600A JP2009504619A (ja) 2005-08-11 2006-08-09 皮膚科学における局所適用用水中油型エマルション
CA002617963A CA2617963A1 (fr) 2005-08-11 2006-08-09 Emulsion de type huile-dans-eau pour application topique en dermatologie
EP06794313A EP1915133A1 (fr) 2005-08-11 2006-08-09 Émulsion de type huile-dans-eau pour application topique en dermatologie
RU2008108973/15A RU2008108973A (ru) 2005-08-11 2006-08-09 Эмульсия типа масло-в-воде для топического нанесения в дерматологии
BRPI0616520-6A BRPI0616520A2 (pt) 2005-08-11 2006-08-09 emulsão de tipo óleo-em-água, processo de preparação de uma emulsão e seu uso
MX2008002012A MX2008002012A (es) 2005-08-11 2006-08-09 Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia.
CNA2006800374997A CN101304729A (zh) 2005-08-11 2006-08-09 皮肤病学中局部施用的水包油型乳液
KR1020087003334A KR20080033389A (ko) 2005-08-11 2006-08-09 피부과학에 있어서의 국소 적용용 수중유-형 에멀젼
PCT/FR2006/001930 WO2007020349A1 (fr) 2005-08-11 2006-08-09 Émulsion de type huile-dans-eau pour application topique en dermatologie
US12/068,670 US20080207570A1 (en) 2005-08-11 2008-02-08 Topically applicable oil-in-water emulsions and dermatological applications thereof
RU2011125550/15A RU2011125550A (ru) 2005-08-11 2011-06-21 Эмульсия типа масло-в-воде для топического нанесения в дерматологии

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0508524A FR2889662B1 (fr) 2005-08-11 2005-08-11 Emulsion de type huile-dans-eau pour application topique en dermatologie

Publications (2)

Publication Number Publication Date
FR2889662A1 FR2889662A1 (fr) 2007-02-16
FR2889662B1 true FR2889662B1 (fr) 2011-01-14

Family

ID=36273334

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0508524A Expired - Fee Related FR2889662B1 (fr) 2005-08-11 2005-08-11 Emulsion de type huile-dans-eau pour application topique en dermatologie

Country Status (12)

Country Link
US (1) US20080207570A1 (fr)
EP (1) EP1915133A1 (fr)
JP (1) JP2009504619A (fr)
KR (1) KR20080033389A (fr)
CN (1) CN101304729A (fr)
AU (1) AU2006281346B2 (fr)
BR (1) BRPI0616520A2 (fr)
CA (1) CA2617963A1 (fr)
FR (1) FR2889662B1 (fr)
MX (1) MX2008002012A (fr)
RU (2) RU2008108973A (fr)
WO (1) WO2007020349A1 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
PL2526930T3 (pl) 2005-06-01 2014-05-30 Glaxosmithkline Ip Dev Ltd Formulacja witaminowa
FR2892936A1 (fr) * 2005-11-10 2007-05-11 Galderma Res & Dev Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition.
EP2343298B9 (fr) 2005-12-13 2020-05-06 Incyte Holdings Corporation Pyrrolo[2,3-b]pyrimidines et pyrrolo[2,3-b]pyridines substituées par des groupements hétéroaryle en tant qu'inhibiteurs de kinase Janus
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2898499B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
FR2915682B1 (fr) * 2007-05-04 2009-07-03 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
RS53245B2 (sr) 2007-06-13 2022-10-31 Incyte Holdings Corp Soli inhibitora janus kinaze (r)-3-(4-(7h-pirolo(2,3-d) pirimidin-4-il)-1h-pirazol-1-il)-3-ciklopentilpropan-nitrila
EP2008651A1 (fr) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Patch bioérodable
US20100249060A1 (en) * 2009-02-23 2010-09-30 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
WO2010115164A1 (fr) * 2009-04-03 2010-10-07 Medicis Pharmaceutical Corporation Compositions topiques
HRP20192203T1 (hr) 2009-05-22 2020-03-06 Incyte Holdings Corporation 3-[4-(7h-pirolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]oktan- ili heptan-nitril kao jak inhibitori
WO2010135650A1 (fr) 2009-05-22 2010-11-25 Incyte Corporation Dérivés de n-(hétéro)aryl-pyrrolidine de pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines et pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines en tant qu'inhibiteurs de la janus kinase
ES2637447T3 (es) 2009-08-31 2017-10-13 Dr. Reddy's Laboratories Ltd. Formulaciones tópicas que contienen un esteroide
TW201113285A (en) 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
US20110212035A1 (en) * 2010-02-26 2011-09-01 Collegium Pharmaceutical, Inc. Emollient foams for treatment of dermatoses
SI3354652T1 (sl) 2010-03-10 2020-08-31 Incyte Holdings Corporation Derivati piperidin-4-il azetidina kot inhibitorji JAK1
MY161078A (en) 2010-05-21 2017-04-14 Incyte Holdings Corp Topical formulation for a jak inhibitor
JP5917545B2 (ja) 2010-11-19 2016-05-18 インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ Ｊａｋ阻害剤としてのシクロブチル置換ピロロピリジンおよびピロロピリミジン誘導体
HRP20191711T1 (hr) 2011-03-14 2019-12-13 Drug Delivery Solutions Ltd Oftalmološki pripravak
PE20140832A1 (es) 2011-06-20 2014-07-14 Incyte Corp Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
JP5909941B2 (ja) * 2011-09-08 2016-04-27 大正製薬株式会社 ステロイド性抗炎症薬含有外用剤
US9193733B2 (en) 2012-05-18 2015-11-24 Incyte Holdings Corporation Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
TWI702057B (zh) 2012-11-15 2020-08-21 美商英塞特控股公司 盧梭利替尼之緩釋性劑型
ES2900492T3 (es) 2013-03-06 2022-03-17 Incyte Holdings Corp Procesos y productos intermedios para elaborar un inhibidor de JAK
CN105263486A (zh) * 2013-04-04 2016-01-20 现代药品株式会社 改善了皮肤渗透的外用剂组合物
AU2014275195A1 (en) * 2013-06-03 2015-12-10 Tolmar, Inc. Corticosteroid compositions
RS60469B1 (sr) 2013-08-07 2020-07-31 Incyte Corp Dozni oblici sa produženim oslobađanjem za jak1 inhibitor
US20160184431A1 (en) * 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
US9498467B2 (en) 2014-05-30 2016-11-22 Incyte Corporation Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
DE102014010875A1 (de) * 2014-07-25 2016-01-28 Basf Se Transparente Textilpflegemittel
WO2017037663A1 (fr) 2015-09-02 2017-03-09 Cadila Healthcare Limited Compositions topiques comprenant des corticostéroïdes
MX390018B (es) 2015-10-30 2025-03-20 Leo Pharma As Formulaciones de isotretinoina y usos y metodos de las mismas.
AU2018288256B2 (en) * 2017-06-23 2023-09-28 Laboratorios Salvat, S.A. An oil-in-water nanoemulsion composition of clobetasol
TW201924683A (zh) 2017-12-08 2019-07-01 美商英塞特公司 用於治療骨髓增生性贅瘤的低劑量組合療法
PT3746429T (pt) 2018-01-30 2022-06-20 Incyte Corp Processos para a preparação de (1-(3-fluoro-2-(trifluorometil)isonicotinoíl)piperidin-4-ona)
EP3542788A1 (fr) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Composition topique comprenant calcipotriol et dipropionate de bétaméthasone
EP4424328A3 (fr) 2018-03-30 2024-12-04 Incyte Corporation Traitement de l'hidradénite suppurée à l'aide d'inhibiteurs de jak
MX2022004967A (es) * 2019-11-01 2022-05-18 Colgate Palmolive Co Composiciones para el cuidado personal de ph bajo estables y metodos para las mismas.
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms
CN113925800B (zh) * 2021-11-03 2024-09-13 时垠(上海)生物科技有限公司 提高单硬脂酸甘油酯乳化体系乳化能力的方法
KR102831554B1 (ko) * 2022-10-24 2025-07-09 주식회사 코리아나화장품 피부투과촉진 복합물을 포함하는 액정 겔 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
JP3454385B2 (ja) * 1993-10-15 2003-10-06 啓次郎 佐藤 Ｏ／ｗ型皮膚用クリームの製造方法
ES2242218T3 (es) * 1996-11-12 2005-11-01 Pharmacia & Upjohn Co Llc Composiciones farmaceuticas que contienen aceite de semilla del arbol candil.
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
FR2787025B1 (fr) * 1998-12-14 2002-10-11 Oreal Composition sous forme d'emulsion h/e a forte teneur en cire et ses utilisations dans les domaines cosmetique et dermatologique
US6403654B1 (en) * 2000-04-13 2002-06-11 Mariana De Oliveira Compositions for and method of treatment for psoriasis
US6699464B1 (en) * 2001-07-30 2004-03-02 Stiefel Laboratories, Inc. Compositions for treatment of hyperpigmentation and methods for making and using such compositions
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
US20030129208A1 (en) * 2002-01-07 2003-07-10 Alberts David S. Topical application of alpha-DFMO and anti-inflammatory drug for treatment of actinic keratoses
AU2003252187A1 (en) * 2002-05-15 2003-12-02 Engelbrecht, Edna Topical composition for the treatment of inflammatory conditions of the skin
ATE556711T1 (de) * 2003-03-13 2012-05-15 3M Innovative Properties Co Verfahren zur verbesserung der hautqualität
KR101243526B1 (ko) * 2004-08-31 2013-03-20 스티펠 리서치 오스트레일리아 피티와이 리미티드 마이크로에멀젼 및 서브마이크론 에멀젼 방법 및 조성물

Also Published As

Publication number Publication date
FR2889662A1 (fr) 2007-02-16
AU2006281346A1 (en) 2007-02-22
RU2011125550A (ru) 2012-12-27
CN101304729A (zh) 2008-11-12
CA2617963A1 (fr) 2007-02-22
MX2008002012A (es) 2008-03-25
US20080207570A1 (en) 2008-08-28
WO2007020349A1 (fr) 2007-02-22
KR20080033389A (ko) 2008-04-16
AU2006281346B2 (en) 2012-03-29
RU2008108973A (ru) 2009-09-20
BRPI0616520A2 (pt) 2011-06-21
JP2009504619A (ja) 2009-02-05
EP1915133A1 (fr) 2008-04-30

Similar Documents

Publication Publication Date Title
FR2889662B1 (fr) Emulsion de type huile-dans-eau pour application topique en dermatologie
IL237632A (en) Liquid dispenser and method of use
DOP2006000278A (es) Glicosilación en la región variable
BRPI0807667A2 (pt) Composição emulsificada de óleo-em-água
FR2875028B1 (fr) Mecanismes pour la virtualisation de cpu
DE502005009598D1 (de) Partikelstabilisierte emulsionen
EP1901702A4 (fr) Complexes ioniques
EP2050434A4 (fr) Agent hydratant
ATE400565T1 (de) Als antikonvulsive mittel geeignete neue benzokondensierte heteroarylsulfamidderivate
DE602007001191D1 (de) Öl-in-öl-emulsionen
EP1992363A4 (fr) Preparation pour absorption transdermique
EP1806120A4 (fr) Composition pour prevenir ou diminuer la pigmentation
DE602006019342D1 (de) Einparkhilfe-Vorrichtung
DE602005008709D1 (de) Rollsteig
FR2868684B1 (fr) Lingettes antibuee
DE602005022364D1 (de) Selbstbräunendes kosmetikum
DE602005001478D1 (de) Oel-in-Wasser emulgierte Zusammensetzung
EP1805514A4 (fr) Immunodosages pour le topiramate
DE602006000877D1 (de) Emulsionszusammensetzung
FR2865545B1 (fr) Lidar compact
DE602005003621D1 (de) Säure Öl-in-Wasser-Emulsionen
EP1956438A4 (fr) Révélateur liquide
FI20040870A0 (fi) Tela
DE502005005356D1 (de) Tripode-rolle
EP1915126A4 (fr) Nouvelle composition dermatologique

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20130430